| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |